Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Protocol For a Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Celecoxib (SC-58635) In The Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

NCT00141193 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00141193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Protocol For a Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Celecoxib (SC-58635) In The Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2001
Completion date
May 31, 2007
Enrollment
1,561 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma